Vincristine Sulfate
Acute Undifferentiated Leukemia
M.D. Anderson Cancer CenterSmall moleculePhase 3Dormant
BB
70/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 60/ 100
- Competitive Position
- 89/ 100
Competitive context
33 Active assets in the Acute Undifferentiated Leukemia cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Fludarabine Fred Hutchinson Cancer Center | Phase 2 | BB |
Cyclophosphamide Masonic Cancer Center, University of Minnesota | Phase 3 | BB |
Dexasone Therapeutic Advances in Childhood Leukemia Consortium | Phase 3 | BB |
Nivestim Fred Hutchinson Cancer Center | Phase 3 | BB |
Cytarabine Fred Hutchinson Cancer Center | Phase 3 | BB |
View all 50 →
Same molecule, other indications
Vincristine Sulfate is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →